ReviewFrontiers in public health2025
Fighting antimicrobial resistance in Brazil: strengthening diagnostic stewardship, antimicrobial stewardship, and policies for a healthier future.
Review in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- New Delhi Metallo-β-Lactamase Plasmidomes of Intensive Care Unit Clinical and Environmental Enterobacterales Isolates.Open forum infectious diseases · 2026Article
- Reassessing antimicrobial resistance governance in Latin America: the case for antimicrobial consumption as the primary metric of implementation success.Frontiers in public health · 2026Article
- Economic Barriers to Antimicrobial Susceptibility Testing as a Structural Contributor to Antimicrobial Resistance in Low- and Middle-Income Countries: A Narrative Review.Infection and drug resistance · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) constitutes a growing public health crisis in Latin America, with Brazil facing particularly severe challenges. The drivers are multifaceted, prominently including suboptimal antimicrobial prescribing practices. Limited access to quality diagnostics and weak implementation of DS and AMS programmes further impede timely antimicrobial de-escalation and worsen the problem. National surveys confirm this gap; one 2019 survey of 954 hospitals with ICUs found that only 47.5% had implemented an ASP. This review critically examines the current landscape of AMR in Brazil, analyzing policy gaps and implementation challenges across primary, secondary, and tertiary healthcare sectors within the public, supplementary, and private healthcare systems. Key findings underscore the imperative to enhance diagnostic stewardship for optimizing antimicrobial selection, bolster surveillance systems, which now reveal a concerning rise in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.